There is a burgeoning market in the area of handheld, wireless patient diaries used by pharmaceutical and
biotechnology companies in order to monitor patients’ responses to new drug therapies. One company that is
experiencing significant growth is invivodata inc., whose eDiary PRO prompts
patients in studies to answer questions about their real-time experience with a new drug or product. The
FDA is
giving this technology close attention, because they feel data collected in patients’ written diaries is not always
accurate. The goal is to relay as much accurate data as possible in order to monitor patient reactions to drugs and
to make sure they are safe to use.
http://telemedicine.weblogsinc.com/e...4000003028595/